Cargando…
Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease
The differential diagnosis of Parkinson's diseases (PD) is challenging, especially in the early stages of the disease. We developed a microRNA profiling strategy for exosomal miRNAs isolated from cerebrospinal fluid (CSF) in PD and AD. Sixteen exosomal miRNAs were up regulated and 11 miRNAs wer...
Autores principales: | Gui, YaXing, Liu, Hai, Zhang, LiShan, Lv, Wen, Hu, XingYue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741914/ https://www.ncbi.nlm.nih.gov/pubmed/26497684 |
Ejemplares similares
-
NFE2L2 variations reduce antioxidant response in patients with Parkinson disease
por: Gui, YaXing, et al.
Publicado: (2016) -
Altered Cerebrospinal Fluid Exosomal microRNA Levels in Young-Onset Alzheimer’s Disease and Frontotemporal Dementia
por: Tan, Yi Jayne, et al.
Publicado: (2021) -
Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer’s disease
por: Noor Eddin, Ahmed, et al.
Publicado: (2023) -
MicroRNA Profiling in Circulating Exosomes in Oral Squamous Cell Carcinoma: A Systematic Review
por: Y, Dinesh, et al.
Publicado: (2023) -
Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease
por: Irwin, David J., et al.
Publicado: (2020)